Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anixa Biosciences Inc Director's Dealing 2010

Dec 10, 2010

34117_dirs_2010-12-10_2c6c3f96-3b60-4e20-8bec-3125234d1c6d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: COPYTELE INC (COPY)
CIK: 0000715446
Period of Report: 2010-10-31

Reporting Person: HERMS HENRY P (Director, Vice President-Finance & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-11-09 Common Stock G 100000 Disposed 10575 Direct

Footnotes

F1: Amount of securities beneficially owned represents shares held by Henry P. Herms as of October 31, 2010 and excludes shares Mr. Herms has the right to acquire upon exercise of stock options pursuant to CopyTele, Inc. stock incentive plans.

F2: Gift.